FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to the chemical-pharmaceutical and food industries. What is presented is a catalytic method for synthesis of a recovered form of coenzyme Q10 (ubiquinol) which can be used for the rapid preparation of ubiquinol and various based pharmaceutical compositions and biologically active food additives possessing antioxidant and antihypoxant activity. The method for preparing ubiquinol of an oxidised form of coenzyme Q10 is based on the catalytic recovery of Q10 in the presence of a chemical reducing agent, a solvent and trace amounts of a Cu2+ copper catalyst for the pharmaceutical and food applications. In addition to the substantial reduction of the time for preparing ubiquinol, using the catalyst enables reducing the consumption of the chemical reducing agent and energy. Prepared ubiquinol can be used, e.g. for preparing various compositions, including ones in the liquid form and in the form of water-soluble powders containing inclusion complexes.
EFFECT: method for the synthesis of the recovered form of coenzyme Q10 (ubiquinol).
10 cl, 9 ex
Title | Year | Author | Number |
---|---|---|---|
WATER-SOLUBLE MOLECULAR INCLUSION COMPLEX OF REDUCED FORM OF COENZYME Q IN β-CYCLODEXTRIN AND METHOD FOR PREPARATION THEREOF | 2011 |
|
RU2509760C2 |
PROCESS FOR PRODUCTION OF REDUCED FORM OF COENZYME Q | 2016 |
|
RU2613103C1 |
UBIQUINOL COMPOSITION FOR PARENTERAL ADMINISTRATION AND METHOD FOR ITS PRODUCTION | 2016 |
|
RU2635993C1 |
METHOD FOR QUANTITATIVE DETERMINATION OF COENZYME Q ANTIOXIDANT IN SUBSTANCE THROUGH CYCLIC VOLTAMMETRY | 2010 |
|
RU2454660C1 |
LIPOSOMAL AGENT BASED ON UBIQUINOL AND PREPARATION METHOD THEREOF | 2015 |
|
RU2605616C1 |
METHOD FOR CORRECTION OF LIPOPEROXIDATION ACCOMPANYING HYPOLIPIDEMIC THERAPY OF PATIENTS WITH METABOLIC SYNDROME | 2011 |
|
RU2458687C1 |
NANODISPERSE COENZYME Q10 COMPOSITION AND METHOD FOR MAKING THEREOF | 2009 |
|
RU2411027C1 |
SOLID DISPERSIONS Q | 2016 |
|
RU2742579C2 |
POLY-(PARA-DIHYDROXY-PARA-PHENYLENE)-THIOSULFOACID SODIUM SALT AS REGULATING AGENT OF CELL METABOLISM AND ANTI-HYPOXIC AGENT, PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2257202C2 |
METHOD OF CORRECTING MENSTRUAL IRREGULARITIES IN WOMEN WITH METABOLIC SYNDROME | 2022 |
|
RU2813333C1 |
Authors
Dates
2014-12-20—Published
2013-05-31—Filed